Iran, Islamic Republic of vs Paraguay: Average cost of multi drug-resistant tuberculosis treatment
Iran, Islamic Republic of
28,730 constant 2022 US$
in 2022
Paraguay
11,664 constant 2022 US$
in 2024
Iran, Islamic Republic of rank
3rd
Paraguay rank
5th
Average cost of multi drug-resistant tuberculosis treatment over time
- Iran, Islamic Republic of
- Paraguay
How they compare
Iran, Islamic Republic of currently reports 28,730 constant 2022 US$ against 11,664 constant 2022 US$ in Paraguay, a difference of 17,066 constant 2022 US$.
That makes Iran, Islamic Republic of's figure about 2.5 times Paraguay's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Paraguay ahead.
Iran, Islamic Republic of ranks 3rd and Paraguay ranks 5th of 92 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8,842 constant 2022 US$ | 2,559 constant 2022 US$ | 6,283 constant 2022 US$ | Iran, Islamic Republic of |
| 2020s | 16,665 constant 2022 US$ | 2,160 constant 2022 US$ | 14,505 constant 2022 US$ | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Iran, Islamic Republic of or Paraguay?
- Iran, Islamic Republic of, at 28,730 constant 2022 US$ against 11,664 constant 2022 US$ in Paraguay as of 2022.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Iran, Islamic Republic of and Paraguay?
- 17,066 constant 2022 US$, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Paraguay?
- 5 years are reported by both, from 2017 to 2022.
- How do Iran, Islamic Republic of and Paraguay rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Iran, Islamic Republic of ranks 3rd and Paraguay ranks 5th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.